Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/liv.14984 http://scihub22266oqcxt.onion/10.1111/liv.14984 34152690!?!34152690 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34152690&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Liver+Int 2021 ; 41 (9): 1988-1998 Nephropedia Template TP {{tp|p=34152690|t=2021. COVID-19 and the liver: A 2021 update |pdf=|usr=}}{{34152690}} gab.com Text COVID-19 and the liver: A 2021 update JO: Liver Int http://www.kidney.de/pget.php?&tw=1&pmid=34152690 #FOAvip In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Wuhan, China and has since resulted in a global pandemic in excess of 165 million reported infections and 3.4 million attributable deaths. COVID-19 is primarily a respiratory illness, which may be complicated by pneumonia and acute respiratory distress syndrome. SARS-CoV-2 is also responsible for numerous extrapulmonary manifestations involving the haematologic, cardiovascular, renal, gastrointestinal and hepatobiliary, endocrinologic, neurologic, ophthalmologic and dermatologic systems. This review will discuss the pathophysiology of COVID-19; focusing on the mechanisms and outcomes of liver injury associated with COVID-19; its impact on chronic liver disease (CLD); management of CLD during the COVID-19 pandemic and the long-term impact of COVID-19 on CLD. Twit Text FOAVip COVID-19 and the liver: A 2021 update ????Liver Int http://www.kidney.de/pget.php?&tw=1&pmid=34152690 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34152690 #FOAvip English Wikipedia <ref>{{Cite pmid|34152690}}</ref> COVID-19 and the liver: A 2021 update #MMPMID34152690 Spearman CW; Aghemo A; Valenti L; Sonderup MW Liver Int 2021[Sep]; 41 (9): 1988-1998 PMID34152690show ga In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Wuhan, China and has since resulted in a global pandemic in excess of 165 million reported infections and 3.4 million attributable deaths. COVID-19 is primarily a respiratory illness, which may be complicated by pneumonia and acute respiratory distress syndrome. SARS-CoV-2 is also responsible for numerous extrapulmonary manifestations involving the haematologic, cardiovascular, renal, gastrointestinal and hepatobiliary, endocrinologic, neurologic, ophthalmologic and dermatologic systems. This review will discuss the pathophysiology of COVID-19; focusing on the mechanisms and outcomes of liver injury associated with COVID-19; its impact on chronic liver disease (CLD); management of CLD during the COVID-19 pandemic and the long-term impact of COVID-19 on CLD. |*COVID-19[MESH] |*Liver Diseases/epidemiology[MESH] |Humans[MESH] |Pandemics[MESH]COVID-19 and the liver: A 2021 update (epmc).pdf DeepDyve Pubget Overpricing